|
Volumn 61, Issue 4, 2006, Pages
|
Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACT;
CONFLICT OF INTEREST;
COURT;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG LABELING;
DRUG MANUFACTURE;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
HEALTH CARE PERSONNEL;
INTERNATIONAL COOPERATION;
LAW;
LEGAL LIABILITY;
PHYSICIAN;
POLICY;
PRESCRIPTION;
PURE FOOD AND DRUG ACT;
RESPONSIBILITY;
REVIEW;
RISK REDUCTION;
UNITED STATES;
DRUG INDUSTRY;
DRUG LABELING;
DUTY TO WARN;
FEDERAL GOVERNMENT;
GOVERNMENT REGULATION;
HISTORY, 20TH CENTURY;
HUMANS;
LEGISLATION, DRUG;
PHARMACEUTICAL PREPARATIONS;
PRESCRIPTIONS, DRUG;
STATE GOVERNMENT;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 33845582585
PISSN: 1064590X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (9)
|
References (0)
|